BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pang QM, Chen SY, Xu QJ, Fu SP, Yang YC, Zou WH, Zhang M, Liu J, Wan WH, Peng JC, Zhang T. Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar. Front Immunol 2021;12:751021. [PMID: 34925326 DOI: 10.3389/fimmu.2021.751021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Saeed Y. Title: Immunotherapy; a ground-breaking remedy for spinal cord injury with stumbling blocks: An overview. Front Pharmacol 2023;14:1110008. [PMID: 36778022 DOI: 10.3389/fphar.2023.1110008] [Reference Citation Analysis]
2 Zhang M, Xia T, Lin F, Yu J, Yang Y, Lei W, Zhang T. Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm. Transpl Immunol 2023;76:101766. [PMID: 36464219 DOI: 10.1016/j.trim.2022.101766] [Reference Citation Analysis]
3 Medvediev VV, Oleksenko NP, Pichkur LD, Verbovska SA, Savosko SI, Draguntsova NG, Lontkovskyi YA, Vaslovych VV, Tsymbalyuk VI. Implantation Effect of a Fibrin Matrix Associated with Mesenchymal Wharton’s Jelly Stromal Cells on the Course of an Experimental Spinal Cord Injury. Cytol Genet 2023;57:19-34. [DOI: 10.3103/s0095452723010073] [Reference Citation Analysis]
4 Rybachuk O, Savytska N, Pinet É, Yaminsky Y, Medvediev V. Heterogeneous pHPMA hydrogel promotes neuronal differentiation of bone marrow derived stromal cellsin vitroandin vivo. Biomed Mater 2023;18. [PMID: 36542861 DOI: 10.1088/1748-605X/acadc3] [Reference Citation Analysis]
5 Xia Y, Zhu J, Yang R, Wang H, Li Y, Fu C. Mesenchymal stem cells in the treatment of spinal cord injury: Mechanisms, current advances and future challenges. Front Immunol 2023;14:1141601. [PMID: 36911700 DOI: 10.3389/fimmu.2023.1141601] [Reference Citation Analysis]
6 Pang QM, Deng KQ, Zhang M, Wu XC, Yang RL, Fu SP, Lin FQ, Zhang Q, Ao J, Zhang T. Multiple strategies enhance the efficacy of MSCs transplantation for spinal cord injury. Biomed Pharmacother 2023;157:114011. [PMID: 36410123 DOI: 10.1016/j.biopha.2022.114011] [Reference Citation Analysis]
7 Szymoniuk M, Litak J, Sakwa L, Dryla A, Zezuliński W, Czyżewski W, Kamieniak P, Blicharski T. Molecular Mechanisms and Clinical Application of Multipotent Stem Cells for Spinal Cord Injury. Cells 2022;12. [PMID: 36611914 DOI: 10.3390/cells12010120] [Reference Citation Analysis]
8 Zhang Y, Zhao X, Zhang Y, Zeng F, Yan S, Chen Y, Li Z, Zhou D, Liu L. The role of circadian clock in astrocytes: From cellular functions to ischemic stroke therapeutic targets. Front Neurosci 2022;16:1013027. [PMID: 36570843 DOI: 10.3389/fnins.2022.1013027] [Reference Citation Analysis]
9 Fu SP, Chen SY, Pang QM, Zhang M, Wu XC, Wan X, Wan WH, Ao J, Zhang T. Advances in the research of the role of macrophage/microglia polarization-mediated inflammatory response in spinal cord injury. Front Immunol 2022;13:1014013. [PMID: 36532022 DOI: 10.3389/fimmu.2022.1014013] [Reference Citation Analysis]
10 Myatich A, Haque A, Sole C, Banik NL. Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury. Neural Regen Res 2023;18:940-6. [PMID: 36254972 DOI: 10.4103/1673-5374.355749] [Reference Citation Analysis]
11 Li C, Zhao J, Qin T, Jin Y, Duan C, Wu T, Romani MD, Cao Y, Lu H, Hu J. Comprehensive analysis of m6A methylation modification in chronic spinal cord injury in mice. J Orthop Res 2022. [PMID: 36205185 DOI: 10.1002/jor.25457] [Reference Citation Analysis]
12 Li Q, Guo Y, Xu C, Sun J, Zeng F, Lin S, Yuan Y. Therapy of spinal cord injury by folic acid polyethylene glycol amine-modified zeolitic imidazole framework-8 nanoparticles targeted activated M/Ms. Front Bioeng Biotechnol 2022;10:959324. [DOI: 10.3389/fbioe.2022.959324] [Reference Citation Analysis]
13 Xiao S, Zhong N, Yang Q, Li A, Tong W, Zhang Y, Yao G, Wang S, Liu J, Liu Z. Aucubin promoted neuron functional recovery by suppressing inflammation and neuronal apoptosis in a spinal cord injury model. Int Immunopharmacol 2022;111:109163. [PMID: 35994851 DOI: 10.1016/j.intimp.2022.109163] [Reference Citation Analysis]
14 Xia M, Zhang Y, Wu H, Zhang Q, Liu Q, Li G, Zhao T, Liu X, Zheng S, Qian Z, Li H. Forsythoside B attenuates neuro-inflammation and neuronal apoptosis by inhibition of NF-κB and p38-MAPK signaling pathways through activating Nrf2 post spinal cord injury. Int Immunopharmacol 2022;111:109120. [PMID: 35944463 DOI: 10.1016/j.intimp.2022.109120] [Reference Citation Analysis]
15 Pinelli F, Pizzetti F, Veneruso V, Petillo E, Raghunath M, Perale G, Veglianese P, Rossi F. Biomaterial-Mediated Factor Delivery for Spinal Cord Injury Treatment. Biomedicines 2022;10:1673. [DOI: 10.3390/biomedicines10071673] [Reference Citation Analysis]
16 Chen X, Wang B, Mao Y, Al Mamun A, Wu M, Qu S, Zhang X, Zhang J, Pan J, Zhu Y, Mo T, Jiang C, Yang L, Xiao J. Zein nanoparticles loaded with chloroquine improve functional recovery and attenuate neuroinflammation after spinal cord injury. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.137882] [Reference Citation Analysis]
17 Lund MC, Ellman DG, Nissen M, Nielsen PS, Nielsen PV, Jørgensen C, Andersen DC, Gao H, Brambilla R, Degn M, Clausen BH, Lambertsen KL. The Inflammatory Response after Moderate Contusion Spinal Cord Injury: A Time Study. Biology 2022;11:939. [DOI: 10.3390/biology11060939] [Reference Citation Analysis]
18 Chen Y, Wu L, Shi M, Zeng D, Hu R, Wu X, Han S, He K, Xu H, Shao X, Ma R. Electroacupuncture Inhibits NLRP3 Activation by Regulating CMPK2 After Spinal Cord Injury. Front Immunol 2022;13:788556. [DOI: 10.3389/fimmu.2022.788556] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Xiao S, Zhong N, Yang Q, Li A, Tong W, Zhang Y, Yao G, Wang S, Liu J, Liu Z. Aucubin promoted neuron functional recovery by suppressing inflammation and neuronal apoptosis in a spinal cord injury model.. [DOI: 10.1101/2022.02.01.478641] [Reference Citation Analysis]